David Eidelberg
Imaging in Parkinson's Disease (eBook, PDF)
64,95 €
64,95 €
inkl. MwSt.
Sofort per Download lieferbar
32 °P sammeln
64,95 €
Als Download kaufen
64,95 €
inkl. MwSt.
Sofort per Download lieferbar
32 °P sammeln
Jetzt verschenken
Alle Infos zum eBook verschenken
64,95 €
inkl. MwSt.
Sofort per Download lieferbar
Alle Infos zum eBook verschenken
32 °P sammeln
David Eidelberg
Imaging in Parkinson's Disease (eBook, PDF)
- Format: PDF
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei
bücher.de, um das eBook-Abo tolino select nutzen zu können.
Hier können Sie sich einloggen
Hier können Sie sich einloggen
Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
Imaging in Parkinson's Disease provides up-to-date information concerning new applications of brain imaging to the study of Parkinson's disease. Written by experts in the field, the book focuses on structural and functional imaging methodologies that have recently been applied to study the natural history of Parkinson's disease, with emphasis on the development of the major motor manifestations of the illness as well as cognitive impairment and dementia.
- Geräte: PC
- mit Kopierschutz
- eBook Hilfe
- Größe: 4.39MB
Andere Kunden interessierten sich auch für
- Robert Jr. KrausUltra-Low Field Nuclear Magnetic Resonance (eBook, PDF)95,95 €
- Peggy MasonMedical Neurobiology (eBook, PDF)63,95 €
- Imaging in SARS (eBook, PDF)104,95 €
- Eduardo E. MD BenarrochNeuroscience for Clinicians (eBook, PDF)68,95 €
- Advances in Alzheimer's and Parkinson's Disease (eBook, PDF)233,95 €
- New Techniques in Gastrointestinal Imaging (eBook, PDF)52,95 €
- Ethan MeltzerHow to Think Like a Neurologist (eBook, PDF)30,95 €
-
-
-
Imaging in Parkinson's Disease provides up-to-date information concerning new applications of brain imaging to the study of Parkinson's disease. Written by experts in the field, the book focuses on structural and functional imaging methodologies that have recently been applied to study the natural history of Parkinson's disease, with emphasis on the development of the major motor manifestations of the illness as well as cognitive impairment and dementia.
Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Oxford University Press
- Erscheinungstermin: 30. August 2011
- Englisch
- ISBN-13: 9780199875146
- Artikelnr.: 38142221
- Verlag: Oxford University Press
- Erscheinungstermin: 30. August 2011
- Englisch
- ISBN-13: 9780199875146
- Artikelnr.: 38142221
- Herstellerkennzeichnung Die Herstellerinformationen sind derzeit nicht verfügbar.
David Eidelberg received his MD from Harvard Medical School in 1981. After completing residency training in neurology at Harvard, he pursued fellowship training in functional brain imaging research in London and New York. He is currently Head of the Center for Neurosciences at The Feinstein Institute for Medical Research. He is also director of the new NIH Morris K. Udall Center for Parkinson's Disease Research and Susan and Leonard Feinstein Professor of Neuroscience at The Feinstein Institute. He also serves on the editorial boards of several major journals including Annals of Neurology and is Associate Editor of The Journal of Neuroscience .
* Contributors
* Chapter 1: Dopaminergic Imaging in Parkinson's DiseaseD: PET, A. Jon
Stoessl and Biju Gopalakrishnan
* Chapter 2: Dopaminergic Imaging in Parkinson's DiseaseD: SPECT,
Christoph Scherfler and Werner Poewe
* Chapter 3: Cerebral Glucose Metabolism and Blood Flow in Parkinson's
Disease, Yilong Ma, Schichun Peng, Vijay Dhawan, and David Eidelberg
* Chapter 4: Structural Abnormalities in Parkinson's Disease: MRI and
Related Methods, Kathrin Reetz and Ferdinand Binkofski
* Chapter 5: Transcranial Sonography in Parkinsonian Syndromes, Daniela
Berg
* Chapter 6: Parkinsonian Tremor, Ioannis U. Isaias and Angelo Antonini
* Chapter 7: Atypical Parkinsonian Syndromes, Kathleen L. Poston
* Chapter 8: Brain Activation Studies in Parkinson's Disease, L.K.
Prashanth and Antonio P. Strafella
* Chapter 9: Functional Markers of Cognition in Parkinson's Disease:
18F-FDG and H215O Positron Emission Tomography Studies, Paul Mattis
and Maren Carbon
* Chapter 10: Imaging Cognitive Dysfunction in Parkinson's Disease:
Cholinergic Neurotransmission and Protein Aggregation, Nicholaas I.
Bohnen and Kirk A. Frey
* Chapter 11: Imaging Inflammation in Parkinsonian Syndromes, David J.
Brooks
* Chapter 12: Functional Imaging Biomarkers for the Assessment of
Parkinson's Disease Progression, Chris C. Tang and David Eidelberg
* Chapter 13: Effects of Treatment: Pharmacologic, Alain Dagher
* Chapter 14: Neuroimaging in Levodopa Induced Dyskinesia, Shigeki
Hirano
* Chapter 15: Effects of Surgical Treatment, Anna L. Bartels and Klaus
L. Leenders
* Chapter 16: Cell-Based Therapies: Imaging Outcomes, Paola Piccini and
Marios Politis
* Chapter 17: Imaging Applications to Parkinson's Disease Clinical
Trials, Martin Niethammer and Andrew Feigin
* Chapter 18: Clinical Applications, Kathleen L. Poston
* Chapter 1: Dopaminergic Imaging in Parkinson's DiseaseD: PET, A. Jon
Stoessl and Biju Gopalakrishnan
* Chapter 2: Dopaminergic Imaging in Parkinson's DiseaseD: SPECT,
Christoph Scherfler and Werner Poewe
* Chapter 3: Cerebral Glucose Metabolism and Blood Flow in Parkinson's
Disease, Yilong Ma, Schichun Peng, Vijay Dhawan, and David Eidelberg
* Chapter 4: Structural Abnormalities in Parkinson's Disease: MRI and
Related Methods, Kathrin Reetz and Ferdinand Binkofski
* Chapter 5: Transcranial Sonography in Parkinsonian Syndromes, Daniela
Berg
* Chapter 6: Parkinsonian Tremor, Ioannis U. Isaias and Angelo Antonini
* Chapter 7: Atypical Parkinsonian Syndromes, Kathleen L. Poston
* Chapter 8: Brain Activation Studies in Parkinson's Disease, L.K.
Prashanth and Antonio P. Strafella
* Chapter 9: Functional Markers of Cognition in Parkinson's Disease:
18F-FDG and H215O Positron Emission Tomography Studies, Paul Mattis
and Maren Carbon
* Chapter 10: Imaging Cognitive Dysfunction in Parkinson's Disease:
Cholinergic Neurotransmission and Protein Aggregation, Nicholaas I.
Bohnen and Kirk A. Frey
* Chapter 11: Imaging Inflammation in Parkinsonian Syndromes, David J.
Brooks
* Chapter 12: Functional Imaging Biomarkers for the Assessment of
Parkinson's Disease Progression, Chris C. Tang and David Eidelberg
* Chapter 13: Effects of Treatment: Pharmacologic, Alain Dagher
* Chapter 14: Neuroimaging in Levodopa Induced Dyskinesia, Shigeki
Hirano
* Chapter 15: Effects of Surgical Treatment, Anna L. Bartels and Klaus
L. Leenders
* Chapter 16: Cell-Based Therapies: Imaging Outcomes, Paola Piccini and
Marios Politis
* Chapter 17: Imaging Applications to Parkinson's Disease Clinical
Trials, Martin Niethammer and Andrew Feigin
* Chapter 18: Clinical Applications, Kathleen L. Poston
* Contributors
* Chapter 1: Dopaminergic Imaging in Parkinson's DiseaseD: PET, A. Jon
Stoessl and Biju Gopalakrishnan
* Chapter 2: Dopaminergic Imaging in Parkinson's DiseaseD: SPECT,
Christoph Scherfler and Werner Poewe
* Chapter 3: Cerebral Glucose Metabolism and Blood Flow in Parkinson's
Disease, Yilong Ma, Schichun Peng, Vijay Dhawan, and David Eidelberg
* Chapter 4: Structural Abnormalities in Parkinson's Disease: MRI and
Related Methods, Kathrin Reetz and Ferdinand Binkofski
* Chapter 5: Transcranial Sonography in Parkinsonian Syndromes, Daniela
Berg
* Chapter 6: Parkinsonian Tremor, Ioannis U. Isaias and Angelo Antonini
* Chapter 7: Atypical Parkinsonian Syndromes, Kathleen L. Poston
* Chapter 8: Brain Activation Studies in Parkinson's Disease, L.K.
Prashanth and Antonio P. Strafella
* Chapter 9: Functional Markers of Cognition in Parkinson's Disease:
18F-FDG and H215O Positron Emission Tomography Studies, Paul Mattis
and Maren Carbon
* Chapter 10: Imaging Cognitive Dysfunction in Parkinson's Disease:
Cholinergic Neurotransmission and Protein Aggregation, Nicholaas I.
Bohnen and Kirk A. Frey
* Chapter 11: Imaging Inflammation in Parkinsonian Syndromes, David J.
Brooks
* Chapter 12: Functional Imaging Biomarkers for the Assessment of
Parkinson's Disease Progression, Chris C. Tang and David Eidelberg
* Chapter 13: Effects of Treatment: Pharmacologic, Alain Dagher
* Chapter 14: Neuroimaging in Levodopa Induced Dyskinesia, Shigeki
Hirano
* Chapter 15: Effects of Surgical Treatment, Anna L. Bartels and Klaus
L. Leenders
* Chapter 16: Cell-Based Therapies: Imaging Outcomes, Paola Piccini and
Marios Politis
* Chapter 17: Imaging Applications to Parkinson's Disease Clinical
Trials, Martin Niethammer and Andrew Feigin
* Chapter 18: Clinical Applications, Kathleen L. Poston
* Chapter 1: Dopaminergic Imaging in Parkinson's DiseaseD: PET, A. Jon
Stoessl and Biju Gopalakrishnan
* Chapter 2: Dopaminergic Imaging in Parkinson's DiseaseD: SPECT,
Christoph Scherfler and Werner Poewe
* Chapter 3: Cerebral Glucose Metabolism and Blood Flow in Parkinson's
Disease, Yilong Ma, Schichun Peng, Vijay Dhawan, and David Eidelberg
* Chapter 4: Structural Abnormalities in Parkinson's Disease: MRI and
Related Methods, Kathrin Reetz and Ferdinand Binkofski
* Chapter 5: Transcranial Sonography in Parkinsonian Syndromes, Daniela
Berg
* Chapter 6: Parkinsonian Tremor, Ioannis U. Isaias and Angelo Antonini
* Chapter 7: Atypical Parkinsonian Syndromes, Kathleen L. Poston
* Chapter 8: Brain Activation Studies in Parkinson's Disease, L.K.
Prashanth and Antonio P. Strafella
* Chapter 9: Functional Markers of Cognition in Parkinson's Disease:
18F-FDG and H215O Positron Emission Tomography Studies, Paul Mattis
and Maren Carbon
* Chapter 10: Imaging Cognitive Dysfunction in Parkinson's Disease:
Cholinergic Neurotransmission and Protein Aggregation, Nicholaas I.
Bohnen and Kirk A. Frey
* Chapter 11: Imaging Inflammation in Parkinsonian Syndromes, David J.
Brooks
* Chapter 12: Functional Imaging Biomarkers for the Assessment of
Parkinson's Disease Progression, Chris C. Tang and David Eidelberg
* Chapter 13: Effects of Treatment: Pharmacologic, Alain Dagher
* Chapter 14: Neuroimaging in Levodopa Induced Dyskinesia, Shigeki
Hirano
* Chapter 15: Effects of Surgical Treatment, Anna L. Bartels and Klaus
L. Leenders
* Chapter 16: Cell-Based Therapies: Imaging Outcomes, Paola Piccini and
Marios Politis
* Chapter 17: Imaging Applications to Parkinson's Disease Clinical
Trials, Martin Niethammer and Andrew Feigin
* Chapter 18: Clinical Applications, Kathleen L. Poston